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Abstract
Previous studies from our laboratory have shown that Cd2 can selectively damage the tight junctions between epithelial
cells in culture. Recently, we have obtained evidence suggesting that this effect may involve the interaction of Cd2 with E-
cadherin, a Ca2-dependent cell adhesion molecule that is localized at the adhering junctions of epithelial cells. To begin to
determine whether or not Cd2 might interact directly with the E-cadherin molecule, we studied the binding of Cd2 to
peptide B, a synthetic, 13-residue polypeptide that corresponds to one of the extracellular Ca2 binding regions of mouse E-
cadherin (also known as uvomorulin). The binding of Cd2 to peptide B was evaluated by using an equilibrium microdialysis
technique and the radioactive isotope 109Cd2. The effects of the binding on the conformation of the peptide were evaluated
by circular dichroism (CD) spectroscopy. The results showed that Cd2 bound to peptide B, with a maximum of one Cd2
binding site per molecule and an apparent dissociation constant (Kd) of 640 WM. The binding of Cd2 was reduced in the
presence of excess Ca2, an effect that was overcome by raising the concentration of Cd2. Both Cd2 and Ca2 caused a
shift in the CD spectrum of the peptide. However, the shift produced by Cd2 was about 3 times the magnitude of that
produced by Ca2. These results indicate that Cd2 can interact with the Ca2 binding site on the peptide B molecule and
distort the secondary structure of the peptide. These findings are consistent with the hypothesis that E-cadherin may be a
direct molecular target for Cd2 toxicity. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cd2 is an important industrial and environmental
pollutant that has been shown to cause severe dam-
age to a variety of organ systems including the lung,
liver, kidney, testis and bone (for reviews, see [1^3]).
In addition, Cd2 has been shown to be teratogenic
and carcinogenic [4]. Although the general toxic ef-
fects of Cd2 have been fairly well characterized, the
speci¢c mechanisms underlying many of these e¡ects
have yet to be elucidated. In a series of recent reports
we have noted that many of the e¡ects of Cd2 in
vivo appear to involve the disruption of junctions
between cells in various endothelial and epithelial
surfaces [5,6], and we have presented evidence show-
ing that Cd2 can selectively damage the tight junc-
tions between cells in several epithelial lines in cul-
ture [5^11]. Results of these studies showed that
exposure to micromolar concentrations of Cd2 for
1^4 h causes the cells to separate from each other
without killing them, or altering levels of ATP [5]
or glutathione [6]. This e¡ect coincides with a drop
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in the transepithelial electrical resistance, a reorgan-
ization of the actin cytoskeleton, and changes in the
structure of the adhering and occluding junctional
complexes [5,8,9].
Evidence from these previous studies suggests that
Cd2 produces its junctional e¡ects by interacting
with a Ca2-sensitive site on the basolateral cell sur-
face [5,9^11]. In considering potential candidates for
this site, we feel that a likely possibility is the Ca2-
dependent cell adhesion molecule, E-cadherin. E-cad-
herin is an integral, transmembrane, Ca2-binding
glycoprotein that belongs to the cadherins family of
Ca2-dependent cell adhesion molecules [12,13]. In
epithelial cells, E-cadherin is primarily localized at
the adhesion belts of the adhering junctional com-
plexes (zonulae adherens) where it plays a key role
in homophilic Ca2-dependent cell^cell adhesion [12^
15]. The protein contains an intracellular domain
that is linked to the actin cytoskeleton though a
group of molecules called catenins, a transmembrane
domain, and an extracellular domain that contains
the putative Ca2-binding sites, as well as the adhe-
sive regions of the molecule [12^20].
Several lines of evidence suggest that E-cadherin
may be a target for Cd2 toxicity in epithelial cells.
First, the initial junction-perturbing e¡ects of Cd2
involve the adhering junctions [5,8]. As was noted
previously, E-cadherin is closely associated with ad-
hering junctions [15]. Second, the disruption of inter-
cellular junctions by Cd2 seems to be more pro-
nounced when Cd2 is added to the basolateral cell
surface than when it is added to the apical surface
[7,9], indicating that Cd2 is acting at a site that is
located on the basolateral side of the occluding junc-
tions. Third, the severity of the disruption of inter-
cellular junctions by Cd2 depends on the concentra-
tion of Ca2 in the incubation medium. The e¡ects of
Cd2 are more pronounced when Ca2 is present at
low concentrations and are greatly attenuated when
Ca2 is present is high concentrations [7,9]. This in-
teraction between Ca2 and Cd2 appears to be com-
petitive, suggesting that Cd2 may be competing with
Ca2 for binding sites such as those that are present
on the E-cadherin molecule. Fourth, exposure to
sublethal concentrations of Cd2 causes a pro-
nounced decrease in the amount of E-cadherin that
is associated with the contacts between the cells [7,9].
One of the possible mechanisms to account for
these observations is that Cd2 might interact with
the extracellular Ca2 binding sites on E-cadherin
and alter the adhesive properties of the molecule.
In a preliminary e¡ort to determine whether or not
Cd2 can interact with E-cadherin, we have studied
the binding of Cd2 to peptide B, a 13-residue poly-
peptide that corresponds to calcium binding motif B
of the amino terminal sequence of mouse E-cadherin
[17]. Ozawa et al. [17] have shown that this polypep-
tide can bind Ca2 with an apparent dissociation
constant of about 2 mM. The binding of Ca2 in-
duces a change in the conformation of the polypep-
tide that can be readily detected by a shift in the CD
spectrum [17].
2. Materials and methods
2.1. Materials
Peptide B was synthesized and puri¢ed by Quality
Controlled Biochemicals (Hopkinton, MA). Reactor-
generated 109Cd2 (1.73 mCi/mg), as the chloride
salt, was purchased from New England Nuclear
(Boston, MA). All other chemicals were of the high-
est commercial grade and were purchased from Sig-
ma Chemical (St. Louis, MO).
2.2. Binding of Cd 2+ to peptide B
The binding of Cd2 to peptide B was evaluated
by the equilibrium microdialysis technique described
previously [21]. This method utilized a Spectrum
Model 132430 microdialyzer unit (Spectrum Medical
Instruments, Laguna Hills, CA) containing 10 sam-
ple wells, which were separated from a bu¡er cham-
ber by a membrane having a Mr cuto¡ of 500. Sam-
ples of peptide B (50^100 Wg) in a volume of 0.1 ml
were placed in the sample wells and then dialyzed to
equilibrium at 25‡C against a dialysis bu¡er that
contained 10 mM Tris (pH 7.4), and varying
amounts of non-radioactive CdCl2 (10^20 WM) and
109Cd2 (approximately 1.8U105 dpm/ml). At vari-
ous times, 10-Wl portions of the solutions in the dial-
ysis wells were drawn o¡ and counted for radioactiv-
ity. Each experiment included a group of blanks (i.e.,
wells that did not contain peptide B). The amount of
Cd2 bound to the peptide was calculated as the
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di¡erence between the counts of radioactivity in the
peptide B sample wells at equilibrium and the counts
in the bu¡er chamber. The molar ratios of Cd2/pep-
tide B were calculated from the known speci¢c radio-
activities of the 109Cd2^CdCl2 stock solutions. To
account for any nonspeci¢c adsorption of Cd2 to
the dialyzer unit, the actual free concentration of
Cd2 was estimated from the radioactivity of the
dialysis bu¡er at the end of each experiment. The
binding data were analyzed by non linear regression
using the Prism computer program (Graph Pad Soft-
ware, San Diego, CA). Under these dialysis condi-
tions, equilibrium was typically reached in 24 h. In
addition, there was no signi¢cant leakage of the pep-
tide through the dialysis membrane over the course
of the experiments.
2.3. Circular dichroism (CD) spectroscopy
CD measurements were made with a Jasco J-710
Spectropolarimeter housed in the Biomedical Re-
search Resources Laboratory at the University of
Illinois at Chicago. Peptide B (0.5 mg/ml) was dis-
solved in 10 mM Tris bu¡er containing either EDTA
(2 mM), Ca2 (2 or 20 mM) or Cd2 (0.25, 0.5, 1, 2
or 20 mM). The CD spectra of the samples were
recorded at 25‡C over a range of 250^200 nm, at a
scan speed of 50 nm/min, with a 1.0-mm light path.
After subtracting the spectra for the respective sol-
vent systems, the molar ellipticities of the samples
were calculated as degrees cm2/dmol using the Jasco
data handling software, with an estimated mean res-
idue molecular mass of 104.7.
3. Results
3.1. Binding of Cd 2+ to peptide B
Fig. 1 is a schematic diagram showing the struc-
ture of E-cadherin and the amino acid sequence of
peptide B. Ozawa et al. [17] previously showed that
Ca2 can bind to the peptide with an apparent dis-
sociation constant (Kd) of about 2 mM. Results of
our studies utilizing the microdialysis technique
showed that Cd2 can also bind to peptide B. Fig.
2 shows the binding as a function of Cd2 concen-
tration. Note that the binding was saturable with a
maximum of about one Cd2 binding site per peptide
B molecule and a Kd of about 640 WM.
Fig. 1. Schematic structure of E-cadherin and the amino acid sequence of peptide B.
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3.2. E¡ects of Ca 2+ on the Binding of Cd 2+ peptide B
In light of the previous observations that the junc-
tion-perturbing e¡ects of Cd2 are greatly reduced in
the presence of excess Ca2 [7], we felt that it would
be of interest to examine the e¡ects of Ca2 on the
binding of Cd2 to peptide B. Fig. 3 shows the bind-
ing of varied concentrations of Cd2 (10 WM, 100
WM or 1 mM) to peptide B in the presence and ab-
sence of 1 mM Ca2. Note that at a Cd2 concen-
tration of 10 WM, the binding of Cd2 was reduced
to near zero when Ca2 was included in the dialysis
solution. However, the inhibitory e¡ect of Ca2 was
less pronounced when Cd2 was present at a con-
centration of 100 WM, and was completely overcome
when Cd2 was present at a concentration of 1 mM.
These results suggest that Cd2 can compete with
Ca2 for the binding site on the peptide B molecule.
3.3. E¡ects of Cd 2+ and Ca 2+ on the CD spectrum of
peptide B
In order to determine whether or not Cd2 and
Ca2 might di¡erentially alter the conformation of
peptide B, we examined the e¡ects of the ions on
the CD spectrum of the peptide. As may be seen in
Fig. 4, Ca2 at a concentration of 2 mM, caused a
signi¢cant decrease in the molar elipticity at 220 nm.
The nature and magnitude of this decrease was sim-
ilar to that described previously by Ozawa et al. [17],
and most likely re£ected a change in the conforma-
tion of the peptide [17,22,23]. Increasing the concen-
tration of Ca2 from 2 mM to 20 mM caused no
greater shift in the spectrum, indicating that this
was the maximum spectral shift, and hence, the max-
imal conformational change that Ca2 was able to
produce. Cd2 also caused a decrease in the molar
ellipticity at 220 nm. However, the maximal shift
produced by Cd2 was about 3 times the magnitude
of that produced by Ca2. This suggests that while
Cd2 can bind to the Ca2 binding site of peptide B,
it alters the conformation of the peptide to a much
greater extent than does Ca2.
The graph on the left in Fig. 5 shows the e¡ects of
various concentrations of Cd2 on the CD spectrum
of peptide B. Note that the magnitude of the de-
crease in the molar elipticity at 220 nm was directly
related to the concentration of Cd2 that was
present. The graph on the right in Fig. 5 shows the
magnitude of the Cd2-induced spectral shift at 220
nm as a function of Cd2 concentration. Note that
the shift was about one half maximal at a Cd2 con-
centration of 480 WM, a concentration that is in rea-
sonably good agreement with the apparent dissocia-
tion constant for the binding of Cd2 as determined
Fig. 2. Binding of Cd2 to peptide B as a function of Cd2
concentration. Samples of peptide B were dialyzed for 24 h
against solutions containing varied concentration of CdCl2 and
109Cd2 as described in Section 2. Each point represents the
mean þ S.D. of 4^11 replicate samples from a total of 10 sepa-
rate experiments. The results were analyzed by nonlinear regres-
sion using the Prism computer program (r2 = 0.84, Kd = 640,
Bmax = 1.02).
Fig. 3. Binding of Cd2 to peptide B in the absence and pres-
ence of Ca2. Samples containing peptide B, and either 10 WM,
100 WM or 1 mM Cd2 were dialyzed to equilibrium in the ab-
sence and presence of 1 mM Ca2. Values represent the
mean þ S.D. of 3^11 replicate samples from nine separate ex-
periments.
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by the equilibrium dialysis technique (see Fig. 2 for
comparison).
If Cd2 and Ca2 were in fact competing for the
same site on the peptide B molecule, one would ex-
pect that high concentrations of Ca2 should be able
to prevent the Cd2-induced change in the conforma-
tion of the peptide. Fig. 6 shows the shifts in the CD
spectra that occurred in the presence of either 500
WM Cd2, 8 mM Ca2 or both ions together. Note
that Cd2 caused a much greater shift in the CD
spectrum than did Ca2, even though Cd2 was
present at a lower concentration. However, when
both ions were present together, the spectral shift
was essentially identical to that produced by Ca2
alone. The most likely explanation for this ¢nding
is that the relatively high concentrations of Ca2
can preferentially bind to the polypeptide and, there-
by, inhibit the binding of Cd2 and prevent the
Cd2-induced conformational change.
4. Discussion
Based on the results of studies utilizing epithelial
cell lines in culture, we have suggested that E-cadher-
in may be the molecular target on which Cd2 acts to
disrupt epithelial cell^cell junctions [7,8,10,21]. The
working hypothesis that we have proposed is that
Fig. 4. E¡ects of Cd2 and Ca2 on the CD spectrum of peptide B. The CD spectra of peptide B solutions containing either EDTA
(2 mM), Ca2 (2 mM or 20 mM) or Cd2 (2 mM or 20 mM) were recorded and analyzed as described in Section 2.
Fig. 5. Concentration dependence of the Cd2-induced shift in the CD spectrum of peptide B. The CD spectra of solutions of peptide
containing either 2 mM EDTA or varied concentrations of Cd2 were recorded and analyzed as described in Section 2. (Left) Spectra
that were obtained under the various conditions. (Right) Magnitude of Cd2-induced change in the molar elipticity at 220 nM as a
function of Cd2 concentration.
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Cd2 can displace Ca2 from binding sites on the
extracellular domain of E-cadherin and, thereby alter
the adhesive properties of the molecule. The results
of the present studies show that Cd2 can interact
with the Ca2-binding site on a relatively simple po-
lypeptide analog of E-cadherin and cause a pro-
nounced distortion in the secondary structure of
the molecule. Although several important issues
have yet to be resolved, these ¢ndings lend additional
support for the hypothesis that E-cadherin may be a
direct molecular target for Cd2 toxicity.
In considering these ¢ndings, there are several key
issues that need to be addressed. One of the most
basic issues concerns the relationship between the
structure of peptide B and the structure of the native
E-cadherin molecule. E-Cadherin is a complex trans-
membrane glycoprotein that includes an extracellular
domain, a transmembrane region and an intracellular
domain [12^20]. The extracellular domain contains
the Ca2-binding and adhesive regions of the mole-
cule, whereas the intracellular domain is linked to the
catenins and cytoskeletal actin ¢laments. While the
exact structure of the native E-cadherin molecule has
yet to be elucidated, studies utilizing recombinant
polypeptide analogs of the extracellular regions of
E-cadherin indicate that the molecule has a high de-
gree of secondary and tertiary structure [18^21]. The
adhesive function of E-cadherin involves a highly
speci¢c structural interaction between the extracellu-
lar domains of E-cadherin molecules from adjacent
cells. Upon binding calcium, the extracellular domain
of E-cadherin becomes more rigid and can form a
complex dimeric structure with the homologous re-
gion of E-cadherin from an adjacent cell [21]. Peptide
B is a relatively simple analog of only one of the
many postulated Ca2-binding regions of E-cadher-
in. While the free molecule contains little secondary
or tertiary structure, it can bind Ca2 and assume a
more rigid conformation [17]. Substitution of lysine
for the ¢rst aspartate residue in peptide-B abolishes
the Ca2 binding ability. Most signi¢cantly, recombi-
nant E-cadherin in which the corresponding aspar-
tate has been replaced by lysine loses it adhesive
capacity [17]. In light of these ¢ndings, peptide B
would appear to be an appropriate model for study-
ing the interaction of metals with the Ca2 binding
sites on E-cadherin.
The second key issue concerns the relative a⁄nities
of Cd2 and Ca2 for the binding site on the peptide
B molecule. While the results of our studies indicate
that both Cd2 and Ca2 can interact with the bind-
ing site on peptide B, Cd2 appears to have a higher
a⁄nity for the binding site than does Ca2. Our es-
timate of the Kd for the binding of Cd2 is about 640
WM, whereas the previously reported Kd for the bind-
ing of Ca2 is about 2 mM [17]. The greater a⁄nity
of Cd2 for the binding site is also evidenced by the
fact that millimolar concentrations of Ca2 were
needed to signi¢cantly decrease the binding of
Cd2, which was present at a much lower concentra-
tion (10 WM or 100 WM). It should be noted that the
Kd for the binding of Cd2 to peptide B is somewhat
higher than concentrations of Cd2 (10^20 WM) that
cause the disruption of cell^cell junctions [5^10]. This
apparent discrepancy is most likely due to the rela-
tive simplicity of the peptide B molecule in compar-
ison to native E-cadherin. One would expect that
metals such as Ca2 and Cd2 would bind with a
higher a⁄nity to more complex analogs of E-cadher-
in that have a higher degree of secondary and terti-
ary structure. Recent studies utilizing a recombinant
140 amino acid analog of E-cadherin, termed E-cad1,
indicate that this is the case. Tong et al. [18] have
shown that Ca2 can bind to E-cad1 with an appa-
rent Kd of 160 WM and we have found that Cd can
bind to the molecule with an apparent Kd of about
20 WM [22].
Fig. 6. Ca2 prevents the Cd2-induced shift in the CD spec-
trum of peptide B. The CD spectra of solutions of peptide B
containing either EDTA (2 mM), Ca2 alone (8 mM), Cd2
alone (500 WM), or Ca2 (8 mM) and Cd (500 WM) together,
were recorded and analyzed as described in Section 2.
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A closely related issue concerns the e¡ects of Cd2
and Ca2 on the structural conformation of peptide
B. Our results indicate that Cd2 and Ca2 can dif-
ferentially alter the conformation of the peptide.
Both ions cause a decrease in the molar elipticity at
220 nm, an e¡ect that is classically associated with
Ca2-binding polypeptides [17,23,24]. However, the
magnitude of the decrease produced by Cd2 was
about 3 times that of Ca2, suggesting that Cd2
causes a pronounced distortion of the peptide B mol-
ecule. This is signi¢cant because if Cd2 and Ca2
can di¡erentially a¡ect the secondary structure of a
simple peptide, such as peptide B, it would seem
reasonable to expect that Cd2 could cause even
more pronounced distortions of complex polypepti-
des such as E-cad1, or the E-cadherin molecule itself.
Such a distortion of secondary and tertiary structure
could profoundly a¡ect the spatial orientation of the
adhesive regions of E-cadherin.
Because of its ability to interact with a wide vari-
ety of biologic molecules, it seems unlikely that any
single mechanism can explain all of the cytotoxic
actions of Cd2. However, the possibility that Cd2
can bind to E-cadherin and alter the function of this
important cell adhesion molecule could have impor-
tant implications regarding the mechanisms of Cd2
toxicity in a variety of tissues, as well as the mecha-
nisms underlying the teratogenic and carcinogenic
e¡ects of Cd2 (for discussion of this point see
[5,6,8]). In addition, the ability of Cd2 to disrupt
E-cadherin dependent cell^cell junctions is a factor
that must be considered in studies examining the
e¡ects of Cd2 on epithelial transport process in vi-
tro.
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